semaglutide neuroprotection Results from the latest clinical trials show semaglutide, a drug used to treat type 2 diabetes and help with weight loss under the brand names Rybelsus, Ozempic, and Wegovy, does not slow Semaglutide's Alzheimer's Trial Failure: Rethinking

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) has emerged as one of the most popular regenerative peptides in 2026

Today, some 22 million or more American adults may be living with the disease

In elder patients with Cyanocobalamin , the effect on the nervous system and the spinal cord is more severe

AstraZeneca plc maintains a presence in the incretin-based therapy market through its established portfolio of DPP-4 inhibitors, while actively evaluating pipeline opportunities in next-generation GLP-1 multi-agonist molecules

Manufacturers could also benefit from monitoring restrictions and identifying alignment to GLP-1 clinical value story, while keeping eyes open for partnership opportunities